# The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease

> **NCT00121550** · PHASE3 · COMPLETED · sponsor: **Copenhagen Trial Unit, Center for Clinical Intervention Research** · enrollment: 4372 (actual)

## Conditions studied

- Heart Disease
- Cardiovascular Disease

## Interventions

- **DRUG:** clarithromycin

## Key facts

- **NCT ID:** NCT00121550
- **Lead sponsor:** Copenhagen Trial Unit, Center for Clinical Intervention Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2000-04
- **Final completion:** 2002-09
- **Target enrollment:** 4372 (ACTUAL)
- **Last updated:** 2016-08-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00121550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00121550, "The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00121550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*